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Cytotoxic, thymus-derived lymphocytes (T cells)  which can specifically lyse cultured 
target cells in vitro also function in vivo in a number of immune reactions of mice; these 
include:  graft versus  host  reactions,  host  versus graft reactions  (reviewed  m  1),  the 
response  to  virus  infections  (reviewed  in  2,  3),  and  tumor rejection  (reviewed  in  1). 
Cytotoxic T cells appear to be preoccupied with cell surface structures coded for by the K 
andD regions of the major murine histocompatibility (H-2) complex (1-13). Thus, these T 
cells seem to monitor cell surfaces for the foreign antigen in functional association with 
self-markers (probably the serologically defined transplantation antigen). 
Although cytotoxic T cells have been studied in vitro with respect to their specificity 
and the actual  mechanism of cytotoxicity (reviewed in  1),  our knowledge about their 
physiological effector role in vivo remains elusive.  Circumstantial evidence exists that 
alloreactive T cells are essential  for the elimintion of H-2-incompatible tumor cells  or 
tissue grafts (1, 12). There is also strong suggestive evidence that in vitro cytotoxic virus- 
immune T  cells  act similarly against virus-infected target cells  in vivo (2,  3,  6).  This 
conclusion derives from the fact that the parameters of T-cell-mediated immunity (i.e., 
kinetics of generation of effector T cells, specificity, and H-2 restriction), of mice infected 
with ectromelia virus  (mouse pox)  or lymphocytic choriomeningitis virus  (LCMV) ~ as 
assayed in vitro parallel the ones in vivo (2, 3, 7, 8). In these two murine virus infections, 
T  cells  are  necessary for the  rapid  elimination  and/or for restricting growth of virus 
(reviewed in 2, 3) during the early 3-5 days of a primary infection as shown in adoptive 
transfer experiments. Antibody-forming  cells are, at least in the adoptive transfer models 
studied,  not  mandatory; however,  they may be  important  in  inhibiting  spreading  of 
extracellular virus and in protecting the host against reinfection. 
What then is the role in vivo of these virus-specific T cells that are cytotoxic in 
vitro  and,  if they  are  also  lytic  in  vivo,  how  do  they  exert  their  antiviral 
function? Two possible  mechanisms  are:  (a)  Cytotoxic T  cells  can  lyse virus- 
infected cells  before infectious virus progeny is  assembled  and  released  (Fig. 
la);  (b)  T  cells  do not  lyse  infected cells,  but  rather  upon recognition of the 
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Fro.  1.  Two possible mechanisms by which immune T cells could control virus production 
and/or spreading:  (a) Cytotox]c T cells lyse acutely infected cells during the eclipse phase 
before infectious viral progeny are assembled and released  (b) T cells do not actually lyse 
acutely infected target cells, but upon recognition of specific vlrally induced cell surface 
antigens  release immune  interferon or other lymphokmes  such  as  migration inhibitory 
factor (MIF),  which can cause inactivation of released virus directly or by activation of 
macrophages  (M ¢b). (The T-cell receptor may be formed by one single or two linked, but 
independent clonally expressed recognition sites, 6 ) 
relevant  viral and self-cell surface  antigens  the T  cells release  soluble mediators 
which then  indirectly  prevent  virus  spread.  The release  of immune  interferon  or 
lymphokines  that  activate  macrophages  to increased  virocidal capacity  could be 
involved  in this  process,  and  some  supporting  evidence  for this  second  mecha- 
nism  exists  (reviewed  in  2,  14)  (Fig.  1 b).  The  results  of  experiments  with 
vaccinia  virus  described  here  provide  evidence  in  support  of the  first  mecha- 
nism. 
Materials and Methods 
M~ce.  6- to 9-wk-old B10 D2 (H-2 Q, BALB/c (H-2 ~), and B10.BR (H-2 ~) were purchased from 
The Jackson Laboratory,  Bar Harbor,  Maine. 
V~rus and Immunization  The WR strain of vaccima virus was a gift from Dr  W. K. Joklik, 
Duke Umversity,  Durham,  N.  C  Mine were infected intravenously  (i v.)  with 8  x  10  ~ plaque 
forming  units  (PFU),  and  spleen  cells were  harvested  6  days  later  (6,  10,  11). The  methods 
employed for the preparation of cells and tissue culture medmm have been described (6). 
Virus T~tratmns  V]rus PFU were determined on Veto cells as described by Early et al. (15). 
PFU  present  in  individual  wells  of hemagglutmation  trays  were  determined  by  vigorously 
plpettmg  supernate  plus  all  cells  out  of each  well.  The  suspensions  were  freeze-thawed  and 
sonlfied  for  10  s  before  fourfold  dilutions  were  plaqued  on  Vero  cell  according  to  described 
techmques  (15)  in  24-hole,  16-mm plates  (Lmbro  Chemical  Co.,  New Haven,  Conn.).  For the 
infectious center assay, the infected target cells were plpetted out of individual wells and washed 
twice m  medium  Fourfold dilutions were mixed w]th Vero cells and plated into 24-hole, 16-mm 
plates. 
Antiserum  AKR ant1-0  C3H was purchased  from Bionetics,  Kensington,  Md.  (cat.  8301-01, 
Lot no  231-61-5). 5 x  l0  T  spleen cells were treated with 1 ml of a 1:10 diluhon of the antiserum for 
30 mln at room temperature  Rabbit complement (C) was added at a 1:6 dilution for 30 mm at 37°C 
(6). 
5~Cr Release Assay.  The fibrosarcoma J774 (H-2 ~) target cell line originating from BALB/c 
and the fibroblast L929 (H-2 ~) cell line originating from C3H mice have been described previously 
(6). The tests were all performed in fiat-bottomed hemagglutination trays (Falcon Plastics, Div. of 
BioQuest, Oxnard, Calif.)  1-3 x  104 target cells were seeded per well and after adherence labeled 
with 51Cr, washed,  and then infected with vaccinia virus at a  multiphcity of infection (MOI) of 
about three.  Spleen cells were then overlaid and percent ~Cr release determined  after various 
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Presentatmn of Data  Means __- SEM of triplicates or quadruplicates were compared by using 
Student's t  test. 
Results 
In  a  preliminary experiment it was determined at  what time  after acute 
infection of cultured cells with vaccinia virus, virus progeny was demonstrable 
in J774 target cells. 1 x  104 J774 were infected with about three PFU per cell and 
washed three times after 1 h. At intervals, total log~o PFU were determined per 
104 cells. Between 2.5 _  0.2 and 2.8 _  0.3 lOglo PFU/104 cells were found at 1, 2, 
and 3 h, 4.0 _+ 0.2 at 4 h, 4.8 +_ 0.3 at 5 h, 5.2 _+ 0.4 at 7 h, 5.4 _+ 0.5 at 10 h after 
infection.  Thus,  virus  titers  increase  after  3-4  h.  After  12  h  infected J774 
released  virtually  all  of their  ~lCr  label  spontaneously  into  the  supernate 
indicating cell death.  Antiviral and cytotoxic activity of immune spleen cells 
were therefore assayed from 1-5 h and 1-10 h after acute infection of target cells 
(Table I). 
The  vaccinia infected J774  target cells were lysed completely by immune 
spleen cells from H-2  compatible mice immunized with vaccinia virus.  When 
assayed 5 h  after infection, the virus titers measured as PFU were reduced by 
1.65  loglo,  i.e.  about  30-fold,  in  the  wells  overlaid  with  immune syngeneic 
lymphocytes (Table  I).  Virus  titers  in  the  test  wells  overlaid  with  normal 
syngeneic or normal or immune allogeneic B10.BR spleen cells were not re- 
duced, although the allogeneic immune B10.BR (H-2  ~)  spleen cells were cyto- 
toxic on syngeneic infected L-cell target cells (H-2~). During the interval of 5-10 
h  after initiation of infection of the target cells virus titers increased slightly, 
about two to threefold in all wells except in those wells where H-2 ~ immune 
spleen cells had lysed virtually all targets by 5 h  (Table I). This suggests that if 
soluble factors had been released upon specific T-cell interactions they were not 
efficient in reducing viral titers measurably. 
The kinetics of cytolytic and  antiviral  activity correlated (Table II).  4-day 
immune spleen cells were cytolytic and reduced viral titers, but both to a lesser 
extent than 6 day immune spleen cells. By 8 days both specific activities were 
lOW. 
To demonstrate more directly that cytolytic activity of T cells was antiviral 
when the target cells were lysed before assembly of infectious virus progeny we 
examined  the  antiviral  effect of cytotoxic,  virus-immune T  cells  separately 
during the period of 1-4 h  or during the interval of 4-8 h  after initiation of 
infection of target cells with virus (Table III). Cytotoxic T cells caused lysis of 
about 90% of the target cells irrespective of the time interval chosen. During the 
period of 1-4 h after infection of the target cells immune spleen cells lysed 91% of 
the infected target cells and reduced, when compared with normal spleen cells 
(Group C), the number of virus-producing target cells (infectious centers) per 
well by about 1.2 loglo (Group D). In the same wells the total number of PFU per 
well was  also  decreased by about  1.3  log~o as  compared to  control wells.  In 
contrast, although immune spleen cells were highly cytotoxic when tested on 
infected targets during the period of 4-8 h after infection, they did not reduce the 
number of infectious centers or of the total number of PFU per well (Group G) 
when compared with controls (Groups E and F). The total numbers of PFU are ROLF  M.  ZINKERNAGEL  AND  ALANA  ALTHAGE  647 
TABLE  I 
Antwtral and Cytotoxtc Actlwty of Vaccinia Immune T Cells Assayed In Vitro on Acutely 
Vaceinm Virus-Infected Target Cells 
Test time-interval after initiation of the infection of J774 (H- 
2 a) target cells* 
Mouse strain  Spleen  1-5 h  1-10 h 
cells 
Loglo PFU/  Percent s~Cr  Log~o PFU/  Percent 51Cr 
well  release  well  release 
B10.D2 (H-2 a)  Normal  4.60  _+  0.355  8.7  ±  0.5  5.11  _+  0.30  32.7  +_  1 1 
Immune  2.95  +  0  17§  80.9  ±  1.111  2.97  ±  0.21~1  100.1  +_ 2 211 
B10 BR (H-2  A)  Normal  4.47  ±  0 20  12.3  -+ 0.6  5.17  _  0.18  27.0  ___ 0.8 
Immune¶  4.30  ±  0.15  10.9  ±  1.1  4.96  ±  0.22  27.1  _+  1 0 
* 3  x  104 target cells per well were labeled with 5~Cr, washed, and infected with vaccinia virus at a 
MOI of three for 1 h before. 5~Cr release and total virus PFU/well were determined in parallel at 
the end of the time intervals tested  The killer to target cell ratio was 60:1. 
5 Means _+ SEM of triplicates. 
§ Sigmficantly different from control values, P  <  0 01. 
IIP <  0.001 
¶ B10.BR immune spleen cells lysed vacclma infected L cells (H-2 ~  ) to 65 2  ___ 1 2% as compared to 
20 1 +_ 0.6% by immune B10 D2 cells. 
TABLZ  II 
Time-Course of the Generation In Vivo of Vwus-Specific Cytotoxic 
Antwwal Actwzty Assessed In Vttro 
Time after in-  B10 D2 spleen cells 
fection 
J774 (H-2 a) target cells were infected 
for 1 h  and tested during the interval 





Normal  4 55  ±  0.185  7 0  ±  0.5 
Vaccinia immune  4  3.80  +- 0.15§  40.7  ~  0,~l 
Vaccmla immune  6  3 09  ±  0.37§  85.3  __ 2.{~[ 
Vaccima immune  8  4.38  __ 0.20  18.7  __  1.111 
* See Table I. 
5 Means _  SEM of tmphcates. 
§ Sigmficantly different from control value, P  <  0.05. 
II P  <  o,ool. 
relatively low when compared to numbers of infectious center. However, the two 
determinations differ technically, since only the samples that were examined for 
total  PFU per well were freeze-thawed and  sonicated for  10 s.  Furthermore, 
vaccinia virus is strongly membrane associated and not readily dissociated. This 
could explain some considerable loss of detectable PFU. The effector cell respon- 
sible for the cytolytic and antiviral effect in vitro is a T cell by several criteria: 
(a) the effector cells are anti~  +  c' sensitive (Table IV); (b) the effector functions 
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TABLE  III 
Comparison of Cytotoxic with Antwtral Activity of Vacctnta Immune Lymphocytes Measured 
by slCr Release and by Infectious Center Assay to Assess Reductmn of Virus-Progeny- 
Producing Target Cells 
Total hours elaps- 
Group  After acute mfechon for 1 h, target  mg between mfec-  Infectmus centers  Total PFU/well*  Percent S'Cr 
cells were overlmd with  tmn of targets and  per well*  release*  $ 
determmahon of 
A  Medium for 1 h  2  3 62 _+ 0 09§  2 81  ± 0 20§  5 1 ± 0 3§ 
B  Medium for 3 h  4  3 68 ±  0 05  4 61  ± 0 25  9 2 ±  0 5 
C  Normal BALB/c for 3 h  4  3 86 ±  0 11  4 50 ± 0 16  9 7 ± 0 7 
D  Immune BALB/c for 3 h  4  2 46 ± 0 121]  3 21  ± 0 1{~]  91 1 ±  1 0¶ 
E  Immune BALB/c for 7 h  8  2 63 -+ 0 1511  3 38 ±  0 1311  98 4 ±  1 3¶ 
F  Medmm for 3 h  + medium for 4 h  8  4 27 ± 0 15  4 87 ± 0 15  22 3 ±  1 0 
G  Medium for 3 h  +  normal BALB/c  8  4 25 _+ 0 22  4 90 ÷ 0 10  20 3 -* 0 8 
for4h 
H  Medium for 3 h  + immune BALB/c  8  4 17  -+ 0 20**  4 76 ± 0 12"*  88 5 ±  1 2¶ 
for4h 
*  The numbers of infectious centers or of total PFU per well were  determined as described m  Materials and Methods 
3 ×  104 J774 target cells were overlaid with 2 ×  10  ~ spleen cells 
§  Means ±  SEM of quadrupheate determinations 
[]  Stgmficantly smaller than medmm or normal cells control, P  <  0 001 
¶  Slgmficantly greater than ~Cr release by medium or normal cells, P  <  0 001 
** Not significantly different from medium or normal cells control 
TABLE IV 
T-CeU Dependence of Antwtral Effect of Cytotoxtc  Spleen Cells In V~tro* 
Spleen  cells  Cell treatment 
J774 (H-2 d) targets  tested  1-5 h  after 
refection  with  vaccmla  virus 
Percent  slCr 
LOglo PFU/well 
release 
B10.D2  (H-2 ~) 
Normal 
Immune 
None  4  79  _+  0  02  25 2  _+  1.0 
None  2.78  _+  0  10  97.5  -+  1  9 
Normal  AKR  +  C'  2  73  _+  0.09  101  3  _  2.2 
AKR  ant1-0  C3H  +  C'$  4  66  _+  0.10§  21.1  _+  0.7§ 
B10.BR  ~H-2  j') 
Immune[  4.60  _+  0  15  21  0  -+  0  8 
Normal  None  4.85  +_  0.10  18.7  +_  0  7 
*  Target  cells and  5'Cr release  test  were  performed  as described  m  Table  I 
$  AKR  anh-0  C3H  treatment  lysed  43%  of the  spleen  cells specifically. 
§  Means  -+  SEM  of trtphcates.  Stgmficantly  different  (P  <  0,001) from  normal  AKR 
+  C'  or no treatment,  but  not  different  from  normal  spleen  cells. 
]1  B10.BR  immune  spleen  cells lysed vaccmla-infected  L929 (H-2  t) target  cells to 40.5 
_+  0.8%  as compared  to  10.9  _+  0.3  by  B10.D2  immune  spleen  cells 
typical of the T-cell response with a rapid onset after day 4 and a rapid decline 6 
days after infection (Table II). 
Discussion 
These experiments demonstrate that T-cell-mediated, virus-specific cytolysis 
acts antivirally only during the period after virus penetration and uncoating 
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phase) but before virus progeny assembles. If infected target cells are lysed after 
virus reassembles, virus-specific cytotoxic T cells do not have an obvious anti- 
viral effect. 
Since vaccinia immune cytotoxic T cells are generated very early during virus 
infections,  can  be  detected  in  vitro  by  day  4,  and  peak  at  4-6  days  when 
neutralizing antibodies are not yet, or barely, demonstrable (2, 14), the cytolytic 
T-cell-mediated effector mechanism  is probably crucial  in rapidly controlling 
primary  virus  infections.  Although  (Fig.  1),  this  is  certainly  not  the  only 
immune antiviral effector mechanism, all evidence suggests that in the pox and 
LCMV models it is an early and very potent one. 
The results are compatible with those obtained in vivo with mouse pox and 
LCMV (7,  8) in which adoptively transferred  immune  spleen cells  (that were 
cytolytic in  vitro)  reduced  up  to  four log,o of PFU  in  spleens  of preinfected 
recipients within 24 h. They also confirm the conclusions that cells infected with 
mouse pox become susceptible to attack by cytotoxic T  cells at about 3 h  after 
infection,  and  that  the  relevant  changes  on  cell  membranes  occur probably 
within the first hour after infection (15). T cells are specific not only for a viral 
antigen but also for a self-cell surface marker coded in H-2K or H-2D. Whether 
this is best explained by the "altered self" or the "dual recognition" hypothesis 
of T-cell recognition is not relevant for this discussion (6). However, this direct 
T-cell-mediated cytolytic antiviral effector mechanism could yield a mechanistic 
explanation for the finding that these T cells recognize and react to viral antigen 
together with H-2K or H-2D rather than with the H-2I structures. 
All viruses as a whole group can, although differentially according to certain 
host-cell ranges (tropisms), infect virtually any cell of multicellular organisms. 
Therefore,  if this  cytolytic effector mechanism  is important,  the immunologi- 
cally relevant self-markers recognized by T cells must have two characteristics: 
first,  they have to be ubiquitous,  and  second,  the  self-markers  or structures 
closely linked to them have to be structures where the cytolytic signal can be 
delivered  efficiently.  Major transplantation  antigens  satisfy both  conditions. 
They have been demonstrated in various amounts on all cells (17) and T-cell- 
mediated cytolysis apparently is most efficient when delivered through H-2K- or 
H-2D-coded cell surface structures (18).  In contrast H-2I-coded structures (e.g., 
Ia)  are not ubiquitous and are expressed mainly on macrophages  and  B  cells 
(17). Also, although under selected experimental conditions of allogeneic stimu- 
lation Ia may serve as target for allogeneic cytolysis, in syngeneic virus-specific 
cytolysis, such a  mechanism  is not detectable in vitro or in vivo (3,  5-8).  The 
facts that  viruses  lose their  infectious and  biological identity for some hours 
while the host cell is susceptible to immunological  attack,  and that virus can 
actively infect virtually any cell distinguishes them  (and cells carrying muta- 
tions or tumor antigens)  from biologically inert  (i.e.,  nonviral)  or chemically 
inert antigens  (i.e., chemically nonreactive with cell surface markers  [9]) such 
as toxins. 
Considerable experimental  evidence indicates that,  like viruses,  inert  anti- 
gens have to be presented on cell surfaces in order to be immunogenic for T cells 
(for review see 19). For this to occur, however, these antigens have to be actively 
phagocytized since they are inert,  i.e., passive towards cells. Obviously the T- 650  ANTIVIRAL  ACTIVITY  OF  CYTOTOXIC  T  CELLS 
cell-mediated effector mechanism is not wanted to be  cytolytic for handling 
toxins or probably intracellular bacteria.  2 Since these agents do not lose their 
infectious and biological identities and properties, cytolysis would release them 
from cells but not destroy their harmful activities. The cell surface structures 
coded by the H-2  gene complex may thus be regarded as off-on switches for 
various partially cell-specific  functions. Noncytolytic T  cells interacting with 
distinct H-2I-coded structures may differentially  trigger release of  lymphokines, 
activation of macrophages, or B cells to produce specific (neutralizing) antibod- 
ies. Such mechanisms could lead to destruction or inactivation of inert antigens 
intracellularly or extracellularly. H-2K- or D-coded structures probably function 
as the cells' punch-hole openers which can be specifically operated by cytotoxic  T 
cells. 
Summary 
Virus-immune cytotoxic T cells can inhibit effectively  growth ofvaccinia virus 
in acutely infected target cells in vitro by destroying infected target cells before 
infectious virus progeny is assembled. Together with the fact that virus-specific 
T  cells are demonstrable after 3 days, very early during infection, and with 
strong circumstantial evidence from adoptive transfer models in vivo, these data 
suggest that in some virus infections T cells may in fact act cytolytically  in vivo 
to prevent virus growth and spread and be an important early antiviral effector 
mechanism. 
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